Literature DB >> 301397

Alleviation of carrageenan-induced hepatotoxicity and acronecrosis by aprotinin.

E F Fowler, A W Thomson, C H Horne.   

Abstract

Carrageenan was found to be hepatotoxic in mice. Raised serum transaminase activity after i.p. injection of carrageenan was correlated with histopathological changes in the liver. These included necrosis of individual hepatocytes and focal areas of necrosis, with associated fibrin thrombi, 12 h after carrageenan injection. Increased mitotic activity was observed at 72 h and extramedullary haemopoiesis was noted at Day 5. Acronecrosis, a further manifestation of intravascular coagulation, was evident within 24 h of carrageenan injection, becoming clearly demarcated by Day 5. Treatment with the anti-protease aprotinin alleviated both the hepatotoxicity and the incidence and extent of acronecrosis induced by carrageenan. The possible mechanism underlying the in vivo toxicity of carrageenan and its alleviation by aprotinin is discussed in the light of these and other findings.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 301397      PMCID: PMC2041150     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  12 in total

1.  Selective macrophage cytotoxicity of carrageenan in vivo.

Authors:  J E Sawicki; P J Catanzaro
Journal:  Int Arch Allergy Appl Immunol       Date:  1975

2.  Suppression of primary immunization by carrageenan - a macrophage toxic agent.

Authors:  D E Bice; D G Gruwell; J E Salvaggio; E O Hoffmann
Journal:  Immunol Commun       Date:  1972

3.  Poly-2-vinylpyridine N-oxide reverses the immunosuppressive effects of silica and carrageenan.

Authors:  A Rios; R L Simmons
Journal:  Transplantation       Date:  1972-03       Impact factor: 4.939

4.  Origin and division of liver macrophages during stimulation of the mononuclear phagocyte system.

Authors:  G W Warr; V S Sljivić
Journal:  Cell Tissue Kinet       Date:  1974-11

5.  Carrageenan and delayed hypersensitivity. II. Activation of Hageman factor by carrageenan and its possible significance.

Authors:  H J Schwartz; R W Kellermeyer
Journal:  Proc Soc Exp Biol Med       Date:  1969-12

6.  Evaluation of carrageenan as an immunosuppressive agent and mediator of intravascular coagulation.

Authors:  A W Thomson; A R Wilson; W J Cruickshank; C H Horne
Journal:  Biomedicine       Date:  1976-05

7.  Toxicity of various carrageenans in the mouse.

Authors:  A W Thomson; C H Horne
Journal:  Br J Exp Pathol       Date:  1976-08

8.  Spectrum and possible mechanism of carrageenan cytotoxicity.

Authors:  P J Catanzaro; H J Schwartz; R C Graham
Journal:  Am J Pathol       Date:  1971-08       Impact factor: 4.307

9.  Uptake and storage of degraded carrageenan in lysosomes of reticuloendothelial cells of the rhesus monkey, Macaca mulatta.

Authors:  R Abraham; L Golberg; F Coulston
Journal:  Exp Mol Pathol       Date:  1972-08       Impact factor: 3.362

10.  An examination of the cytotoxic effects of silica on macrophages.

Authors:  A C Allison; J S Harington; M Birbeck
Journal:  J Exp Med       Date:  1966-08-01       Impact factor: 14.307

View more
  3 in total

1.  Serum IgG, IgM and slow alpha-globulin levels in carrageenan-treated rats.

Authors:  E F Fowler; A W Thomson
Journal:  Br J Exp Pathol       Date:  1979-08

2.  Effect of carrageenan on activity of the mononuclear phagocyte system in the mouse.

Authors:  E F Fowler; A W Thomson
Journal:  Br J Exp Pathol       Date:  1978-04

Review 3.  Carrageenan: a review of its effects on the immune system.

Authors:  A W Thomson; E F Fowler
Journal:  Agents Actions       Date:  1981-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.